Journal of Clinical Investigation 2022

6 papers
In 2022, the Journal of Clinical Investigation published research centered on oncology, immunology, and infectious diseases. A primary focus involved the molecular mechanisms of cancer progression, particularly organ-specific metastasis and immune evasion. Key studies examined how IL-20RB facilitates bone metastasis in lung cancer and how KRAS mutations regulate extracellular vesicle transmission to promote lymphangiogenesis in pancreatic cancer. Research also addressed treatment resistance, investigating epigenetic priming and RAD21 amplification as factors in ovarian cancer immunity. Infectious disease research during this period emphasized the characterization of neutralizing antibody responses in patients hospitalized with SARS-CoV-2 Delta and Omicron variants. Additionally, investigators identified a causal link between a Shigella species variant and functional constipation. Other prominent themes included the role of extracellular vesicles as intercellular communication vectors and the identification of conserved molecular switches in inflammatory diseases. Prolific contributors included Adam S. Lauring, Manish M. Patel, and Mark W. Tenforde, reflecting a collaborative effort to understand complex physiological regulators and improve precision delivery for tissue homeostasis.

Top Research Directions

The 12 research directions with Journal of Clinical Investigation 2022 papers, ranked by paper count, next to 2021. Share is the fraction of the edition’s papers in the direction.

#Direction20222021Share 2022Share 20212021 rank
1Cross-Cancer Generalizability of Tumor Regulatory Pathways3050.0%0.0%—
2Epigenome Wide Association Studies of Complex Traits1016.7%0.0%—
3Epitranscriptomic Modulation of Transcript Half-Life1016.7%0.0%—
4Exonuclease Resistance in Circulating RNA Biomarkers1016.7%0.0%—
5Genetic Drivers of Tumor Immune Exclusion1016.7%0.0%—
6Mapping Immune Landscapes with Multi-Parameter Flow Cytometry1016.7%0.0%—
7Optimizing Dosing and Sequencing for Synergistic Combination Therapies1016.7%0.0%—
8Organ-Specific Immunosuppression and Metastatic Resistance1016.7%0.0%—
9Overcoming the Immunosuppressive Tumor Microenvironment1016.7%0.0%—
10Predictive Microbial Signatures for Disease Stratification1016.7%0.0%—
11Prioritizing Candidate Genes through Multi-Omic Integration1016.7%0.0%—
12Transcriptional Repression via Targeted Histone Deacetylation1016.7%0.0%—

Download all directions as CSV

Institutions

Institutions credited by Journal of Clinical Investigation 2022 papers: a paper credits every institution named in its affiliations, once. 35 institutions share 5 credited papers.

#InstitutionPapersShare20212021 rank
104dn2ax39 240.0%0—
2Sun Yat-sen University 240.0%0—
300fb35g87 120.0%0—
400rytkh49 120.0%0—
501px77p81 120.0%0—
602p4far57 120.0%0—
7037p24858 120.0%0—
803bqk3e80 120.0%0—
903fjc3817 120.0%0—
1003vjkf643 120.0%0—
1103yky5015 120.0%18
12043ea4m21 120.0%0—
13049qtwc86 120.0%0—
1404kmpyd03 120.0%0—
1505kje8j93 120.0%0—
16Agency for Science, Technology and Research 120.0%0—
17Chinese Academy of Sciences 120.0%0—
18Duke-NUS Medical School 120.0%0—
19Genome Institute of Singapore 120.0%0—
20Guangdong Provincial People's Hospital 120.0%0—
21Nanjing Normal University 120.0%0—
22Nanjing University 120.0%0—
23National Heart Centre Singapore 120.0%0—
24National University of Singapore 120.0%13
25Northwestern Medicine 120.0%0—
26Northwestern University 120.0%0—
27Ruijin Hospital 120.0%0—
28Shanghai Jiao Tong University 120.0%0—
29South China University of Technology 120.0%0—
30Stony Brook University 120.0%0—

Download all institutions as CSV

About this data

Papers. Journal of Clinical Investigation 2022 lists 6 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2021 use shares, since the edition went from 4 to 6 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 5 of 6 papers (83.3%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-18 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Journal of Clinical Investigation 2022”, https://lacuna.tiptreesystems.com/venue/journal-of-clinical-investigation/2022.

Top Authors

AuthorPapers
Max SY Lau1

Impactful Papers

Papers from Journal of Clinical Investigation 2022 that shaped research clusters.

Influential

Papers

Title
A Shigella species variant is causally linked to intractable functional constipation
Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer
IL-20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer
KRAS mutant–driven SUMOylation controls extracellular vesicle transmission to trigger lymphangiogenesis in pancreatic cancer
Neutralizing antibody responses in patients hospitalized with SARS-CoV-2 Delta or Omicron infection
RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer